Albendazole Anthelmintic Drug Market Key Findings, Company Profiles and Trends till 2028

Albendazole is in a class of drugs known as anthelmintics medication, also known as albendazolum. It inhibits the production or replication of newly hatched insect larvae (worms) in the body. It is used to treat various infections caused by worms such as pork tapeworm and dog tapeworm. It can be used for various purposes in humans and animals. In animals, it is used to treat capillariasis that is caused by Capillaria plica (dogs and cats) and C. felis cati (cats). Capillaria infect the urinary bladder, so they are sometimes referred to as bladder worms.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00022893/?utm_source=OpenPR&utm_medium=10376

Additionally, it has been used to treat filaroides infections and giardia infections in dogs. It works by stopping sugar absorption by worms, so the energy production is diminished and results in immobilization and death of the parasite.

SEGMENTATION

Based on type, the global albendazole anthelmintic drug market is segmented into tablets, capsules and others.
On the basis of application, the market is bifurcated into human and veterinary.

MARKET DYNAMICS
Drivers

- Growing incidences of neurocysticercosis infection and high prevalence of human parasitic worm infections drive the albendazole anthelmintic drug market.
- Rising awareness about soil-transmitted infections and filarial infections in humans and rising incidences of helminthic infection boosts the market growth.
- Rise in awareness about veterinary care favour growth of the global market.
- Growing government initiatives for creating awareness to eradicate the infection and increasing awareness about combination therapy in order to reduce the drug resistance in animals propel market growth.
- Rising innovations in anthelmintic drugs and expanding R&D activities for new drug development fuel the market growth.

Restraints

- Side effects associated with albendazole anthelmintic drugs.
- Rise in multidrug-resistance.

Have a Call with Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00022893/?utm_source=OpenPR&utm_medium=10376

IMPACT OF COVID-19 ON ALBENDAZOLE ANTHELMINTIC DRUG MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The outbreak of COVID-19, has surged an unprecedented demand for medication that are capable of fighting off the novel coronavirus infection. Some companies are validating promising potentials of anthelmintic drug therapy for treatment of COVID-19. As a result, niclosamide has been found to be potentially effective in many countries for treating coronavirus patients. Hence, this led to increased drug demand in the market. Companies in the anthelmintic drugs market are taking extra efforts to conduct clinical trials in existing therapeutic drugs that may be effective in coronavirus treatment, this overall results in high demand for albendazole anthelmintic drug in the forecast period.

Top Players:

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the albendazole anthelmintic drug market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

Amneal Pharmaceuticals Inc
Cipla Inc.
Sun Pharmaceutical Industries Ltd
GlaxoSmithKline
Salius Pharma
Sequent Scientific
K.A. Malle Pharmaceuticals
Jiangsu Qihui
Supharma Chem
Fredun Pharmaceuticals Ltd

Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00022893/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-987

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.